baber/WOPTO huggingface dataset:
Patent NZ-337506-A (NZ)
Title: Detection and differentiation of pathogenic enterobacteria in a sample by providing specific, labelled oligonucleotides probes and optimised primer pairs for amplification using PCR
Inventor: PFEFFER KLAUS
IPC: C12Q1/6823
Filed: 1998-04-21
Abstract: A rapid, high performance assay for the detection of pathogenic E.coli based on TaqmanÖ PCR technique. The method allows the detection of EHEC (enterohemorrhagic Escherichia coli), ETEC (enterotoxigenic strains), EPEC (enteropathogenic strains), EIEC (enteroinvasive strains), EaggEC (enteroaggregative strains) and related enterobacteria that harbour these virulence genes in routine bacteriological laboratories.  Wherein the method includes the hybridization of primer pairs to gene encoding heat labile toxin characteristic for enterotoxigenic E.coli shown.
Patent NZ-337651-A (NZ)
Title: 1,4-substituted cyclic amine derivatives, preparation and use as seretonin antagonists
Inventor: KITAZAWA NORITAKA
IPC: C07D491/056
Filed: 1998-03-31
Abstract: A 1,4-substituted cyclic amine derivative represented by the following formula (I) or a pharmacologically acceptable salt thereof is disclosed, wherein A, B, C, D, T, Y and Z represent each methine or nitrogen; R1, R2, R3, R4 and R5 represent each a substituent; n represents 0 or an integer of 1 to 3; m represents 0 or an integer of 1 to 6; and p represents an integer of 1 to 3. The compound has a serotonin antagonism and is clinically useful as medicament, in particular, for treating, ameliorating and preventing spastic paralysis or central muscle relaxants for ameliorating myotonia.
Patent NZ-337665-A (NZ)
Title: Snooker table with side pockets inwardly spaced on "V" shaped projections (compared to standard table)
Inventor: HEGGIE DAVID WATSON MCINTYRE
IPC: A63D15/00
Filed: 1998-02-05
Abstract: The present invention relates to a snooker table (10) having a conventional rectangular outer frame having opposed major sides (12, 14) and minor sides (16, 18). The playing surface (20) is non-rectangular, in that a pair of arrowhead or 'V' shaped projections (22, 24) extend inwardly from respective major sides (12, 14). The playing surface (20) thus has an hour glass-type shape, and is bounded by a conventional cushion (26). Pockets (28) are provided at opposite corners of the table, as in a conventional snooker table. The projections (22, 24) terminate in similar pockets (30A, 30B), which are located along the same centre-line as the middle pockets of a standard snooker table, but which are spaced inwardly relative thereto. It is stated that the snooker table provides for a snooker type game which is both versatile and challenging.
Patent NZ-502667-A (NZ)
Title: Installation for producing 5-layered corrugated board with alignment of corrugation waves and troughs
Inventor: ENGEL PAUL
IPC: B31F1/28
Filed: 1999-06-16
Abstract: An installation is disclosed for producing 5-layered corrugated board has two supply devices, each for supplying one pasted lined corrugated paperboard (3, 4) and a supply device for supplying a lining sheet (16). The two corrugated pasteboards (3, 4) are supplied in the same layer, at least one layer being oriented in the longitudinal direction in such a way that the wave crests of one corrugated pasteboard (3) correspond to the wave troughs of the other corrugated pasteboard (4), so that a very rigid structure is produced after gluing
Patent NZ-503482-A (NZ)
Title: Fusion proteins comprising HIV-1 tat and/or HIV-nef proteins
Inventor: BRUCK CLAUDINE
IPC: C12N15/49
Filed: 1998-09-17
Abstract: Provided for is a vaccine comprising (a) an HIV Tat protein or derivative linked to either (i) a fusion partner or (ii) an HIV Nef protein or derivative; or (b) an HIV Nef protein or derivative linked to either (i) a fusion partner or (ii) an HIV Tat protein or derivative; or (c) an HIV Nef protein or derivative linked to an HIV Tat protein or derivative  and a fusion partner. The preferred fusion partner is a lipoprotein derived from Haemophilus Influenza  B protein D. A host cell, such as Pichia Pastoris, is a preferred vehicle for expressing the above constructs.
Patent NZ-504664-A (NZ)
Title: Mussel packing with free-flow through hopper and settling into carton
Inventor: COOPER GARRY
IPC: B65B1/04
Filed: 2000-05-18
Abstract: A dispensing hopper includes walls 2, 3 that flex about their mounts 2A, 3A so that the flexing of the walls as product is dispensed onto the walls from above and into the container 5 below the hopper serves to assure the free-flow (no clogging) of the product, such as unshucked muscles, through the hopper into the container.
Patent NZ-508267-A (NZ)
Title: Cap closure
Inventor: VON SPRECKELSEN HENNING
IPC: B65D17/30
Filed: 1999-04-09
Abstract: A bottle is made by blow moulding plastics material to form a body portion, filling the body with liquid and fusing a neck 16 and cap 42 assembly to a flange 12 at the mouth of the body portion. The neck 16 may have a base 20 which has a section 26 separated from the remainder of the base 20 by frangible portions 28. Preferably, the neck 16 and cap 42 are both made by injection moulding, thus having similar tolerances and providing a good fit with each other. When bottling fluid using such bottles, the bodies are blow moulded and then preferably passed directly to a filling station for filling before the neck and cap assembly are fused to the body by means of a layer of heat sealable foil 40 positioned between the neck and body. The foil provides a tamper evident closure for the bottle, and may be sterilised before application to prolong the shelf-life of the packaged fluid, e.g. milk. The bodies are preferably blow moulded using a rotary machine having a series of moulds adapted to pass beneath a single die-head for the supply of plastics material which is blow moulded to form the body.
Patent NZ-508534-A (NZ)
Title: Anti-germ attachment - composition containing a surfactant and a silicone
Inventor: ANSARI SHAMIM ALAM
IPC: A61Q19/00
Filed: 1999-05-28
Abstract: A method for inhibiting attachment of germs to the skin is disclosed, which comprises applying to the skin a composition comprising: (a) a skin cleansing effective amount of a surfactant or mixture of surfactants; (b) a silicone in amounts effective to inhibit attachment of germs to the skin, and rinsing said composition from the skin; wherein the composition is effective in inhibiting the attachment of germs to the skin after rinsing the composition from the skin.
Patent NZ-509183-A (NZ)
Title: Activated carbon filter, ceramic filter element and water purification system comprising both filters
Inventor: KIRKPATRICK ALAN
IPC: C01B32/336
Filed: 1999-03-23
Abstract: A water purification system (1) comprising an activated carbon filter and a porous ceramic filter (3) element (4) are connected in series so that in use water passes sequentially through the activated carbon filter and then through the ceramic filter.  The activated carbon filter comprises particulate activated carbon containing particles of water insoluble ash in an amount of at least 1 % by weight as determined in accordance with ASTM 2866.  The porous ceramic filter element (4) has a proportion of the pores partially occluded to give pores having an effective size across their largest dimension, which is smaller than their true size.
Patent NZ-509927-A (NZ)
Title: Coupling mechanism for power tool body and attachment with ribs and grooves on cylindrical projections
Inventor: DRIESSEN LEO
IPC: B25F3/00
Filed: 2001-02-14
Abstract: A coupling mechanism formed on one portion of a power tool (10) for coupling with a complimentary other portion of the power tool, the mechanism comprising a generally cylindrical projection having a side wall with a radial recess formed therein, the radial recess extending part-circumferentially along the side wall.  A further projection on the side wall which further projection extends both in a direction parallel to the axis of the cylindrical projection and in a direction radially outward from the side wall.
Patent NZ-510845-A (NZ)
Title: Novel substituted indolinones with an inhibitory effect on various kinases and cyclin/CDK complexes
Inventor: ROTH GERALD
IPC: C07D209/36
Filed: 1999-09-22
Abstract: Substituted indolinones of formula (I), their isomers and salts are disclosed, wherein X and R1 to R5 are as described in the specification. These compounds of formula (I), wherein R1 represents a hydrogen atom, a C1-3-alkyl group or a pro-drug radical, have useful pharmacological properties, especially an inhibitory effect on various kinases, on viral cyclin and on receptor tyrosine kinases. The other compounds of formula (I), wherein R1 does not represent a hydrogen atom, a C1-3-alkyl group or pro-drug radical, represent useful intermediate products for producing the above-mentioned compounds.
Patent NZ-515405-A (NZ)
Title: Wood piece imaging for defects by microwave reflection
Inventor: PARKER RICHARD
IPC: G01N22/02
Filed: 2000-05-29
Abstract: A method and apparatus for assessing standing tree stems for readiness for harvesting, or for determining cutting points for processing of felled tree stems, logs (8), or wood pieces, or for assessing stems, logs, or wood pieces for a particular end use, comprises scanning (4) with short-wave or microwave electromagnetic energy and processing the scan data to produce an image indicating the external shape or dimensions of the stem or log (8) and hidden internal characteristics and their position, and assessing the image. Knots and/or whorls (12) which are not visible from the exterior and the depth of the clearwood sheath from the surface may be determined.
Patent NZ-517955-A (NZ)
Title: PD-1, a receptor for B7-4 for modulating the immune response
Inventor: WOOD CLIVE
IPC: A61P29/00
Filed: 2000-08-23
Abstract: A method for modulating an immune response comprises contacting in vitro a cell expressing B7-4 or an immune cell expressing PD-1 with an agent that modulates the interaction of B74 with PD-1 to thereby modulate the immune response. The agent is selected from an activating antibody that recognizes PD-1 and transmits a negative signal via PD- 1; an antibody that recognizes PD-1 a polypeptide comprising an extra cellular domain of SEQ ID NO:2 or SEQ ID NO:4 in multivalent form; a polypeptide comprising an amino acid sequence encoded by a nucleic aid molecule that hybridizes under stringent conditions to the complement of nucleotides encoding amino acids 19-245 of SEQ ID NO:2 or amino acids 19-238 of SEQ ID NO:4 in multivalent form; an antibody that recognizes PD-1 and doesn't transmit an negative signal, a soluble form of B7-4 and an antibody that recognizes B7-4 and a soluble form of PD-1. Also described is a composition that comprises and antigen and the agent as described above, and a assay for screening for compounds that modulate the binding and/or activity of B7-4 and PD-1. An agent that modulates the interaction off PD-1 and B7-4 such that a negative signal is not transmitted via PD-1 can be used in the manufacture of a medicament for treating a subject having a condition that would benefit from up regulation of a immune response. Preferably the condition is a tumor, a neurological disease or an immunosuppressive disease. An agent that modulates the interaction off PD-1 and B7-4 such that a negative signal is transmitted via PD-1 can be used in the manufacture of a medicament for treating a subject having a condition that would benefit from down regulation of an immune response. Preferably the condition is selected from a transplant, an allergy and an autoimmune disorder.
Patent NZ-520821-A (NZ)
Title: Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV, method ofr preparation, and their use
Inventor: ROBL JEFFREY A
IPC: A61K31/454
Filed: 2001-03-05
Abstract: Dipeptidyl peptidase IV (DP 4) inhibiting compounds of formula (I) are disclosed, where x is 0 or 1 and y is 0 or 1 (provided that x = 1 when y = 0 and x = 0 when y = 1); n is 0 or 1; X is CN; and wherein R1, R2, R3 and R4 are as described in the specification. A method is also provided for treating diabetes and related diseases, especially Type II diabetes, and other diseases as set out herein, employing such DP 4 inhibitor or a combination of such DP 4 inhibitor and one or more of another antidiabetic agent such as metformin, glyburide, troglitazone, pioglitazone, rosiglitazone and/or insulin and/or one or more of a hypolipidemic agent and/or anti-obesity agent and/or other therapeutic agent.
Patent NZ-524127-A (NZ)
Title: Method and system for facilitation of wireless e-commerce transactions
Inventor: MAMDANI MALIK
IPC: G06Q20/40
Filed: 2001-07-12
Abstract: A method for facilitating a wireless transaction includes receiving, by a transaction management system, a transaction request and a spoken authentication code from a transaction requester. After authenticating the spoken authentication code, a transaction code is communicated from the transaction management system to a wireless communication device. The transaction code is then optically scanned from a visual display of the wireless communication device.
Patent NZ-529978-A (NZ)
Title: A method of preparing a synergistic analgesic combination of opioid analgesic and cyclooxygenase-2 inhibitor
Inventor: BURCH RONALD MARTIN
IPC: A61K31/12
Filed: 1998-09-17
Abstract: A method of preparing a single pharmaceutical dosage form comprising combining (a) a COX-2 inhibitor and (b) an opioid analgesic selected from the group consisting of methadone, meperidine, levorphanol, hydromorphone, tramadol, pharmaceutically acceptable salts thereof and mixtures thereof to form an analgesic combination; said COX-2 inhibitor having at least 9-fold greater specificity for COX-2 over COX-l either in-vivo (as determined by ED5O measurements) and/or in-vitro (as determined by IC measurements). (62) Divided out of 518778
Patent NZ-531851-A (NZ)
Title: Novel prodrugs of n-h bond-containing compounds and methods of making thereof
Inventor: GUARINO VICTOR R
IPC: C07D305/14
Filed: 2002-10-16
Abstract: Disclosed is a compound having the formula (I), wherein: R1 and R2 are residues of an N-H bond containing pharmaceutical compound being a uracil, a barbital, Iinezolid, carbamazepine, flutamide, paclitaxel, a urea having straight chain or branched substituted or unsubstituted aliphatic groups with or without any additional polar or non-polar functional groups and/or heteroatoms, or a peptide, and R is one of a hydrogen, inorganic residue and an organic residue selected from the group consisting of: a) straight-chain substituted or unsubstituted aliphatic groups, with or without any additional polar or non-polar functional groups and/or heteroatoms; b) branched substituted or unsubstituted aliphatic groups, with or without any additional polar or non-polar functional groups and/or heteroatoms; c) substituted or unsubstituted acyl groups, with or without any additional polar or non-polar functional groups and/or heteroatoms; d) substituted or unsubstituted aromatic groups, with or without any additional polar or non-polar functional groups and/or heteroatoms; e) substituted or unsubstituted cyclic groups, with or without any additional polar or non-polar functional groups and/or heteroatoms; and f) any combination of a), b), c), d) and e) with or without additional polar or non-polar functional groups and/or heteroatoms; and pharmaceutically acceptable salts thereof. Also disclosed is a method of making a prodrug of an N-H bond-containing pharmaceutical compound comprising the reaction illustrated in Reaction Scheme IV, wherein X is any good leaving group, R1 and R2 are residues of an NH-bond-containing pharmaceutical compound and R is as defined above.
Patent NZ-533542-A (NZ)
Title: Chemokine receptor binding heterocyclic compounds with enhanced efficacy
Inventor: CRAWFORD JASON
IPC: A61K31/5377
Filed: 2002-12-23
Abstract: Disclosed is a compound of formula (I) wherein: X and Y are independently N or CR1; Z is O or CR12; each R1 is independently H, halo, alkyl, alkoxy or CF3; each R-2 is independently H or alkyl; R3 is H, alkyl, alkenyl, aryl, alkyl, or aryl wherein each group may contain a heteroatom; each R4 is H, alkyl, halo, alkoxy, aryl or haloaryl; each R5 is independently H; alkyl, alkenyl, hydroxyalkyl, aminoalkyl, alkoxy, aryl, alkyl carboxylic acid, alkylated hydroxyl amine, alkyl oxime wherein each group may contain a heteroatom; hydroxyl, halo, oxime or hydroxyl amine; or two R5 are =NH or =C; each R6 is independently H; alkyl, alkenyl, aryl, arylalkyl, arylsulfonyl; alkyl amide aryl, nitroaryl, alkylamidearyl, carboxy haloalkyl, alkylamino, alkyl ester, aryl carbonyl, ary carbonyl hydroxide, aryl carbonylhalo, alkyl carbonyl wherin each group may contain a heteroatom, or amide, guanidyl, carbonyl, carbamino, or amidino; n1 is 0-4; n2 is 0-1, wherein the * signifies alkynyl may be substituted for CR5=CR5; and n3 is 0-4. Compounds of the type disclosed a useful in the treatment of conditions characterised by the modulation of the CXCR4 or CCR5 receptors including tumours, rheumatoid arthritis, HIV infection, allergic or inflammatory disease.
Patent NZ-534976-A (NZ)
Title: Artificial audible calling system for guidance of dressage rider
Inventor: LOCKWOOD MARTIN
Filed: 2004-08-26
Abstract: To guide a blind equestrian along a path in an arena, sound producing units with loudspeakers A, B, C are positioned around the arena, each unit including a processor that is programmed to produce a unique sound such as a voice message corresponding to the relative position of the unit with respect to the other units and the arena layout. A sighted operator observes the progress of the rider and activates a controller 3 to send a signal to a particular sound producing unit at an appropriate time, the signalled sound producing unit producing the programmed audible signal to be heard by the rider to guide the rider.
Patent NZ-541500-A (NZ)
Title: Polymorph of {6,7-Bis(2-methoxy-ethoxy)-quinazolin-4-yl}-(3e)
Inventor: BUBENDORF ANDRE GERARD
IPC: A61P35/00
Filed: 2004-02-11
Abstract: Disclosed is a crystalline polymorph of [6,7-Bis(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)amine hydrochloride of formula (I). Also disclosed is a process for preparing the polymorph. The polymorph is useful in the treatment of hyperproliferative disorders such as cancers, and is thermodynamically more stable than the known polymorph A and exhibits a better solubility and dissolution rate than the known polymorph B.
Patent NZ-545872-A (NZ)
Title: Integral arm axle/suspension system
Inventor: RAMSEY JOHN E
IPC: B60G3/12
Filed: 2004-10-15
Abstract: An axle/suspension system for a wheeled vehicle, in which the vehicle has a frame, includes an integral arm structure that includes an attachment member for connecting the integral arm structure to the vehicle frame. A flexible transition member is connected to and extends from the attachment member and a truss structure is connected to and extends from the transition member. The flexible transition member may be generally curved or angular and enables pivotal movement of the integral arm structure and cooperates with the truss structure to distribute forces encountered by the axle/suspension system. The truss structure may include a truss member that replaces a conventional axle tube. Optionally, two axle/suspension integral arm structures may be used to capture a conventional axle tube.
Patent NZ-551327-A (NZ)
Title: Method and apparatus for cleaning the interior surface of a pipe section.
Inventor: LAUZON NORMAND
IPC: A61L2/18
Filed: 2005-04-18
Abstract: disclosed is a method for cleaning an interior surface of a processing equipment using a treatment liquid, the processing equipment including a pipe section defining pipe section first and second ends, the pipe section defining a pipe section volume delimited by the pipe section first and second ends, the pipe section being initially at an initial internal pressure, said method comprising: - introducing a predetermined volume of the treatment liquid into the pipe section at a location substantially adjacent the pipe section first end, the predetermined volume being substantially smaller than the pipe section volume; and - circulating the predetermined volume of the treatment liquid through the pipe section by simultaneously - reducing an internal pressure within the pipe section at a location substantially adjacent the pipe section second end to a level substantially below the initial internal pressure; and - increasing an internal pressure within the pipe section at a location substantially adjacent the pipe section first end to a level substantially above the initial internal pressure.
Patent NZ-553696-A (NZ)
Title: Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient
Inventor: TAKAOKA YOSHIKAZU
IPC: A61P31/04
Filed: 2005-09-12
Abstract: Nitrogenous heterocyclic derivative compounds of formula (I), their salts and N-oxides, and solvates are disclosed, (wherein the variables are as defined in the description). These compounds of formula (I) have a CCR5 antagonistic activity, so that they are useful in the prevention and/or therapy for CCR5 mediated diseases, for example, various inflammatory diseases (asthma, gastritis, nephropathy, hepatitis, arthritis, rheumatoid arthritis, rhinitis, conjunctivitis, ulcerative colitis and other inflammatory intestinal failure, etc.), immunologic diseases (autoimmune disease, rejection of transplanted organ (rejection of solid organ transplant graft, rejection of pancreatic islet cell transplant in diabetes, graft-versus-host disease, etc.), immunosuppression, psoriasis, multiple sclerosis, etc.), infectious diseases (human immunodeficiency virus infection, acquired immunodeficiency syndrome, RSV infection, etc.), allergoses (atopic dermatitis, hives, allergic bronchopulmonary aspergillosis, allergic eosinophilic gastroenteritis, etc.), cardiovascular risks (arteriosclerosis, suppression of ischemic reperfusion injury, etc.), acute respiratory distress syndrome, shock caused by bacterial infection, diabetes, cancer metastasis, etc.
Patent NZ-556442-A (NZ)
Title: Canine respiratory coronavirus (CRCV) spike protein
Inventor: BROWNLIE JOHN
IPC: C12N1/19
Filed: 2003-07-01
Abstract: Disclosed is a canine respiratory coronavirus (CRCV) Spike protein, or a 20 amino acid fragment thereof, having at least 90% identity to the sequence disclosed in Fig 4. Further disclosed are methods of inducing the production of anti-CRCV antibodies by administering the aforementioned protein, methods for determining whether a dog has been exposed to CRCV, and methods for identifying a test vaccine capable of preventing canine infectious respiratory disease.
Patent NZ-562494-A (NZ)
Title: Dairy production information system
Inventor: LODER ANDREW
IPC: G06Q30/00
Filed: 2006-04-11
Abstract: A method for allocating dairy end product pricing risk in a dairy production system is disclosed. The method includes providing a fixed price for a future period for a dairy end product to a retailer of the dairy end product, determining a cost of production for the dairy end product, and allocating the difference between the fixed price and the cost of production among each dairy production entity based on the sale of the dairy end product at the fixed price. The cost of production including costs associated with each dairy production entity in the dairy production process.
Patent NZ-563095-A (NZ)
Title: A centrifugal pump for pumping liquid including solid matter
Inventor: ANDERSSON PATRIK
IPC: F04D7/04
Filed: 2006-06-05
Abstract: The disclosure relates to a pump for pumping contaminated liquid including solid matter, comprising a pump housing provided with a rotatable impeller (1) suspended in a drive shaft (3) and having at least one vane (5) , and an impeller seat (2) , at least one part of the impeller (1) and the impeller seat (2) being movable in the axial direction in relation to each other Furthermore, the impeller seat (2) presents at least one groove in the top surface thereof .